PDCD1 and leukemia: The authors showed that the anti-leukemia response was effective against NPM1mut cells when the immunogenic epitope was derived from the mutated region of NPM1 compared with other epitopes/LAA, and these effects were enhanced through the addition of anti-programmed cell death protein 1 (PD-1).